FULC
Fulcrum Therapeutics, Inc.
There isn't enough reported data to score FULC yet.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
FULC Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
FULC's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
FULC PE Valuation
FULC has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
FULC Forward outlook
There aren't enough analyst estimates for FULC to show an outlook.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
FULC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.04 | +$0.08 |
| Q2 2026 | -$1.21 | -$0.05 |
| Q1 2026 | -$1.15 | -$1.14 |
| Q4 2025 | -$1.18 | -$1.02 |
FULC has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
FULC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2024 | $80M | +8991% |
| Q4 2023 | $871K | +27% |
| Q3 2023 | $759K | -36% |
| Q2 2023 | $880K | -53% |
| Q1 2023 | $295K | -89% |
| Q4 2022 | $685K | -86% |
| Q3 2022 | $1.2M | -76% |
| Q2 2022 | $1.9M | -57% |
FULC's revenue has slid since its 2024 peak: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2024 | 66% | +3167 points |
| Q4 2023 | -3214% | +870 points |
| Q3 2023 | -3615% | -1557 points |
| Q2 2023 | -3101% | -1282 points |
| Q1 2023 | -9471% | -8468 points |
| Q4 2022 | -4084% | -3618 points |
| Q3 2022 | -2059% | -1638 points |
| Q2 2022 | -1819% | -1370 points |
FULC's operating margin was 66% last quarter, up 9537 points from the same quarter a year ago, near the top of its range since 2020.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS's revenue has grown year over year every quarter since late 2021: $890M last quarter, up 49% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
FULC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$13.4M | +$898K |
| Q2 2026 | -$16.1M | -$2.3M |
| Q1 2026 | -$18.8M | -$3.5M |
| Q4 2025 | -$17M | +$35K |
| Q3 2025 | -$14.3M | +$4.8M |
| Q2 2025 | -$13.9M | -124% |
| Q1 2025 | -$15.3M | +$10.1M |
| Q4 2024 | -$17M | +$6.2M |
FULC has burned cash in almost every quarter: −$65M over the past year, against −$60M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over FULC on cash generation, producing positive trailing cash flow while its opponent burns cash.
FULC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +52K shares |
| 1 year | +22% | +13.8M shares |
FULC has 76M diluted shares, up 22% from a year ago.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over FULC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
FULC Net Leverage
FULC's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
FULC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.7 | Neutral |
| Stochastic | 36.6 | Neutral |
FULC's weekly RSI is 36 (neutral) and its Stochastic is 37 (neutral).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
FULC PE vs Healthcare Sector
FULC has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
FULC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.70 | 0.5% below |
| 20 week MA | $3.73 | 1.3% below |
| 50 week MA | $6.46 | 43% below |
| 100 week MA | $6.30 | 42% below |
| 200 week MA | $6.10 | 40% below |
FULC is in a downtrend: it's below all five of its weekly moving averages, and 40% below its 200-week average.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
FULC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.0 | $12.5 | -26% |
| 2021 | $12.5 | $18.1 | +45% |
| 2022 | $18.1 | $6.25 | -65% |
| 2023 | $6.25 | $6.75 | +8% |
| 2024 | $6.75 | $4.79 | -29% |
| 2025 | $4.79 | $11.6 | +142% |
| 2026 YTD | $11.6 | $3.68 | -68% |
FULC's yearly returns have swung widely, from +142% in 2025 to −65% in 2022. It's down 68% so far in 2026.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over FULC on returns for 2026, with the stronger performance.